Tobiasson, M, Pandzic, T, Illmann, J, Nilsson, L, Weström, S, Olsson, D, Ejerblad, E, Olsnes Kittang, A, Olesen, G, Werlenius, O, Björklund, A T, Lorentz, F, Rasmussen, B E H, Cammenga, J, Dimitriou, M D, Kytölä, S, Walldin, G, Groenbaek, K, Mielke, S, Waelgaard Jacobsen, S E, beling, F, Cavelier, L, Friis, L S, Dybedal, I, Hellström-Lindberg, E & Weber, D 2020, ' Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers : The Prospective Nordic Study NMDSG14B ', Blood, vol. 136, no. Suppl. 1, pp. 5-6 . https://doi.org/10.1182/blood-2020-138782
Hayden, P J, Iacobelli, S, Pérez-Simón, J A, van Biezen, A, Minnema, M, Niittyvuopio, R, Schönland, S, Meijer, E, Blaise, D, Milpied, N, Márquez-Malaver, F J, Veelken, J H, Maertens, J, Michallet, M, Cammenga, J R, N'Guyen, S, Niederwieser, D, Hunault-Berger, M, Bourhis, J H, Passweg, J, Bermudez, A, Chalandon, Y, Yakoub-Agha, I, Garderet, L & Kröger, N 2020, ' Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP ', European Journal of Haematology, vol. 104, no. 3, pp. 181-189 . https://doi.org/10.1111/ejh.13352 European Journal of Haematology European Journal of Haematology, 2020, 104 (3), pp.181-189. ⟨10.1111/ejh.13352⟩ Digital.CSIC. Repositorio Institucional del CSIC instname European Journal of Haematology, 104(3), 181-189. Wiley-Blackwell European Journal of Haematology, 104(3), 181. Wiley-Blackwell European Journal of Haematology, Vol. 104, No 3 (2020) pp. 181-189 European Journal of Haematology, Wiley, 2020, 104 (3), pp.181-189. ⟨10.1111/ejh.13352⟩ European Journal of Haematology. WILEY
Baliakas, P, Tesi, B, Wartiovaara-Kautto, U, Stray-Pedersen, A, Friis, L S, Dybedal, I, Hovland, R, Jahnukainen, K, Kræsten Raaschou Jensen, K, Ljungman, P, Cecilie F, R C F, Charlotte K, L, Outil, K, Astrid Olsnes, A, Grønbæk, K, Cammenga, J, Lindberg, E H & Andersen, M K 2019, ' Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up ', HemaSphere, vol. 3, no. 6, 321 . https://doi.org/10.1097/HS9.0000000000000321 HemaSphere, Vol 3, Iss 6, p e321 (2019) HemaSphere Baliakas, P, Tesi, B, Wartiovaara-kautto, U, Stray-pedersen, A, Friis, L S, Dybedal, I, Hovland, R, Jahnukainen, K, Raaschou-Jensen, K, Ljungman, P, Rustad, C F, Lautrup, C K, Kilpivaara, O, Kittang, A O, Grønbæk, K, Cammenga, J, Hellström-lindberg, E & Andersen, M K 2019, ' Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults : Recommendations for Genetic Diagnosis, Clinical Management and Follow-up ', HemaSphere, vol. 3, no. 6, e321, pp. 1-10 . https://doi.org/10.1097/HS9.0000000000000321 Baliakas, P, Tesi, B, Wartiovaara-Kautto, U, Stray-Pedersen, A R, Friis, L S, Dybedal, I, Hovland, R, Jahnukainen, K, Raaschou-Jensen, K, Ljungman, P, Rustad, C F, Lautrup, C K, Kilpivaara, O, Kittang, A O, Gr Nbæk, K, Cammenga, J, Hellström-Lindberg, E & Andersen, M K 2019, ' Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults : Recommendations for Genetic Diagnosis, Clinical Management and Follow-up ', HemaSphere, vol. 3, no. 6, e321 . https://doi.org/10.1097/HS9.0000000000000321